DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nitrofurantoin (Nitrofurantoin) - Adverse Event Reports - Other Serious Reactions - Alanine Aminotransferase Increased

 



Index of reports > Cases resulting in other serious reactions (7) > Cases with Alanine Aminotransferase Increased (2)

Below is the selection of adverse event reports related to Nitrofurantoin that includes cases resulting in other serious reactions where reactions include alanine aminotransferase increased.

Adverse event in 84 year old female receiving Nitrofurantoin

Reported by a physician from United States on 2007-06-15

Patient: 84 year old female

Adverse reactions / side effects: Blood Bilirubin Increased, Jaundice, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Oedema Peripheral, Hepatic Failure, Liver Disorder

Suspect drug(s):
Nitrofurantoin
    Dosage: see image
    Start date: 2003-01-14
    End date: 2003-08-01

Nitrofurantoin
    Dosage: see image
    Start date: 2004-09-09
    End date: 2005-11-09

Other drugs received by patient: Cardia; Cozaar; Coumadin; Lipitor



Adverse event in 47 year old female receiving Nitrofurantoin

Reported by a physician from United States on 2007-05-10

Patient: 47 year old female, weighing 83.9 kg (184.6 pounds)

Adverse reactions / side effects: Blood Bilirubin Increased, Blood Bilirubin Unconjugated Increased, Chills, Pain, Urticaria, Headache, Constipation, Fatigue, Oedema, Blood Alkaline Phosphatase Increased, Nausea, Hepatitis Acute, Haemorrhoids, Drug Hypersensitivity, Alanine Aminotransferase Increased, Jaundice Cholestatic, Eosinophil Count Increased, Discomfort, Hepatic Enzyme Increased, Tremor, Faeces Pale, Flushing, Aspartate Aminotransferase Increased, Urine Colour Abnormal, Ocular Icterus, Bilirubin Conjugated Increased, Influenza Like Illness

Suspect drug(s):
Nitrofurantoin
    Dosage: 100 mg, oral
    Administration route: Oral
    Indication: Cystitis
    Start date: 2006-08-11
    End date: 2006-08-13

Estradiol
    Dosage: 0.05 mg, qd, transdermal
    Indication: Oestrogen Replacement Therapy
    Start date: 2006-07-01
    End date: 2006-08-01

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009